Norman D. LaFrance

Insider Reports History

Entity
Individual
Location
Molecular Insight Pharmceuticals, Inc., 160 Second Street, Cambridge, MA
Signature
/s/ Andrew Sims, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Norman D. LaFrance:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PLUS THERAPEUTICS, INC. Chief Medical Officer Stock Option (Right to Buy) 24.1K Feb 22, 2024 Direct

Insider Reports Filed by Norman D. LaFrance

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PSTV PLUS THERAPEUTICS, INC. Feb 22, 2024 1 $0 4 Feb 26, 2024 Chief Medical Officer
PSTV PLUS THERAPEUTICS, INC. Feb 15, 2023 1 $0 4 Feb 17, 2023 Chief Medical Officer
PSTV PLUS THERAPEUTICS, INC. Nov 11, 2021 1 $0 4/A Mar 28, 2022 CHIEF MEDICAL OFFICER
PSTV PLUS THERAPEUTICS, INC. Nov 11, 2021 0 $0 3 Nov 24, 2021 CHIEF MEDICAL OFFICER